FLOAT Through Anxiety: Virtual Reality Application's Efficacy as a Tool to Distract From Negative Emotions and Thoughts
FLOAT Through Anxiety: Examining the Efficacy and Safety of the Virtual Reality Application "Float" as a Tool to Distract From Negative Emotions and Thoughts in People With High Levels of Anxiety and Stress
1 other identifier
interventional
62
1 country
1
Brief Summary
The goal of this clinical trial is to examine the effectiveness and safety of the VR FLOAT application as a tool to reduce negative thoughts and feelings and anxiety symptoms in students with high levels of stress and anxiety. The main questions it aims to answer are:
- 1.Will subjects with high levels of anxiety who will use the FLOAT application experience a more significant relief in feelings of anxiety compared to subjects in the control group?
- 2.Will subjects who are used to using technology find greater comfort in using VR compared to subjects who are not used to it?
- 3.What is the degree of satisfaction with the use of VR and are there any reports of side effects?Participants will \[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets Researchers will compare control group to see The comparison between using FLOAT as a regulation strategy after psychoeducation on emotional regulation and cognitive-behavioral use of a regulation strategy after the same psychoeducation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2023
CompletedFirst Submitted
Initial submission to the registry
June 13, 2023
CompletedFirst Posted
Study publicly available on registry
January 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2024
CompletedApril 17, 2024
April 1, 2024
29 days
June 13, 2023
April 16, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
situational anxiety before session
The State-Trait Anxiety Inventory (STAI) questionnaire. range 20 to 100, with a higher score representing higher levels of anxiety
a week
situational anxiety after session
The State-Trait Anxiety Inventory (STAI) questionnaire. range 20 to 100, with a higher score representing higher levels of anxiety
a week
satisfaction with life
Satisfaction with Life Scale (SWLS). 5 to 35. A high score represents higher life satisfaction and a lower score represents a lower life satisfaction
baseline
satisfaction with life
Satisfaction with Life Scale (SWLS). 5 to 35. A high score represents higher life satisfaction and a lower score represents a lower life satisfaction
week 3, after intervention
Ease of using the technology
System Usability Scale (SUS). scale from 0 to 100. A score higher than 70 indicates good usability, while a score lower than 50 indicates low usability.
week 3, after intervention
Secondary Outcomes (1)
The FLOAT user experience
week 3, after intervention
Study Arms (2)
control
ACTIVE COMPARATORpsychoeducation on emotional regulation and distraction strategy + Application
experimental
EXPERIMENTALpsychoeducation on emotional regulation and distraction strategy + Application with the FLOAT app
Interventions
The experimenter gives the subject psychoeducation about emotional regulation and distraction strategy with the help of a conversation and a presentation.
The subject should wear the VR device, and use the FLOAT application.
psychoeducation on emotional regulation and distraction strategy + Application
Eligibility Criteria
You may qualify if:
- 'moderate' or 'severe' levels of stress and/or anxiety according to the DASS-21 questionnaire
- student
You may not qualify if:
- under the age of 18
- diagnoses of schizophrenia or bipolar disorder, including past or present psychotic conditions
- suicidality
- pregnant women
- do not speak or read Hebrew fluently
- a diagnosis of epilepsy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Haifa
Haifa, Israel
Study Officials
- PRINCIPAL INVESTIGATOR
YAEL ENAV, professor
University of Haifa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Yael Enav
Study Record Dates
First Submitted
June 13, 2023
First Posted
January 9, 2024
Study Start
March 12, 2023
Primary Completion
April 10, 2023
Study Completion
January 20, 2024
Last Updated
April 17, 2024
Record last verified: 2024-04